TY  - JOUR
AU  - Santoro, Cristina
AU  - Fuh, Beng
AU  - Le, Phu Quoc
AU  - Maes, Philip
AU  - Berrueco, Ruben
AU  - Mingot-Castellano, Eva Maria
AU  - von-Mackensen, Sylvia
AU  - Tueckmantel, Claudia
AU  - Cabre-Marquez, Jose Francisco
AU  - Wang, Michael
PY  - 2022
DO  - 10.1111/ejh.13876
UR  - http://hdl.handle.net/10668/19949
T2  - European journal of haematology
AB  - To report the final results of the 2-year TAURUS study, assessing weekly prophylaxis dosing regimens of octocog alfa (Kovaltry®/BAY 81-8973) used in standard clinical practice in patients with moderate-to-severe haemophilia A. TAURUS (NCT02830477) is...
LA  - en
PB  - Wiley
KW  - Drug switching
KW  - Haemophilia A
KW  - Octocog alfa
KW  - Prophylaxis
KW  - Prospective study
KW  - Humans
KW  - Factor VIII
KW  - Hemophilia A
KW  - Hemorrhage
KW  - Prospective Studies
KW  - Treatment Outcome
TI  - Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81-8973): Final results of the global real-world study, TAURUS.
TY  - research article
VL  - 110
ER  -